Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

PRQR holding history

ProQR Therapeutics N.V. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PRQR overviewAll 13F holders of PRQRFull Q2 2026 holdings

Shares (Q2 2026)
1,184,314
Value
$2.20M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of PRQR by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,184,314$2.20M<0.1%+480,991+68.4%AddedHolders
Q1 2026703,323$1.14M<0.1%+120,101+20.6%AddedHolders
Q4 2025583,222$1.18M<0.1%−73,790−11.2%ReducedHolders
Q3 2025657,012$1.40M<0.1%+277,749+73.2%AddedHolders
Q2 2025379,263$773.7K<0.1%−439,595−53.7%ReducedHolders
Q1 2025818,858$1.09M<0.1%+410,051+100.3%AddedHolders
Q4 2024408,807$1.08M<0.1%+321,830+370.0%AddedHolders
Q3 202486,977$158.3K<0.1%+68,612+373.6%AddedHolders
Q2 202418,365$30.5K<0.1%−27,643−60.1%ReducedHolders
Q1 202446,008$104.4K<0.1%−31,808−40.9%ReducedHolders
Q4 202377,816$154.1K<0.1%+77,816NewHolders
Q3 20230$00.0%−116,792−100.0%Sold outHolders
Q2 2023116,792$189.2K<0.1%+17,013+17.1%AddedHolders
Q1 202399,779$212.5K<0.1%+99,779NewHolders
Q3 20220$00.0%−209,215−100.0%Sold outHolders
Q2 2022209,215$162.0K<0.1%+209,215NewHolders
Q1 20220$00.0%−222,269−100.0%Sold outHolders
Q4 2021222,269$1.78M<0.1%+130,063+141.1%AddedHolders
Q3 202192,206$772.0K<0.1%+34,076+58.6%AddedHolders
Q2 202158,130$392.0K<0.1%+29,754+104.9%AddedHolders
Q1 202128,376$188.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.